O-823 is a drug which is a cannabinoid derivative that is used in scientific research. It is described as a mixed agonist/antagonist at the cannabinoid receptor CB1 meaning that it acts as an antagonist when co-administered alongside a more potent CB1 agonist but exhibits weak partial agonist effects when administered by itself.
This page contains content from the copyrighted Wikipedia article "O-823"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
